Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

EBS Emergent Biosolutions Inc

10,31

0,04 (0,39%)

04 Jan 2025 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/12/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Donald DeGolyer

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Emergent Biosolutions (NYSE:EBS)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Emergent Biosolutions

Emergent Biosolutions (NYSE:EBS)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Emergent Biosolutions

Actualités Emergent Biosolutions Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 17 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Lundi 16 Décembre 2024 ( il y a 3 semaines) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 10 Décembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Jeudi 5 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mercredi 4 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Lundi 2 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Jeudi 21 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 13 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 13 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mardi 12 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mardi 12 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Emergent Biosolutions Inc

Credit Agricole

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales